ArticleJournal of medical biochemistry2025
Amelioration of T lymphocyte subsets, inflammatory factors and gastrointestinal function by traditional Chinese medicine rehabilitation management in postoperative chemotherapy for lung cancer.
Article in Journal of medical biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To analyse the influence of Traditional Chinese Medicine (TCM)-characteristic rehabilitation management on T lymphocyte subsets, inflammatory response, and stress response during the postoperative chemotherapy of lung cancer (LC). Methods: 189 LC patients admitted to our hospital from July 2023 to June 2024 were enrolled in this research. Among them, 107 patients who did not receive TCM-characteristic rehabilitation management were regarded as the control group, while the other 82 patients who underwent such management were designated as the observation group. The levels of inflammatory factors and stress response markers before and after treatment in both groups were compared, including hypersensitive-C reactive protein (hs-CRP), interleukin-6 (IL-6), superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione peroxidase (GSH-Px). The T lymphocyte subsets [CD3+, CD4+, CD8+, and natural killer (NK) cells] and gastrointestinal function were also detected. Results: After the completion of treatment, it was observed that the levels of hs-CRP MDA, and the proportion of CD8+ T lymphocyte subsets in the observation group were significantly reduced compared with the control group (P< 0.05). In contrast, the activities of SOD and GSH-Px, the proportions of CD3+ and CD4+ T lymphocyte subsets, as well as the activity of NK cells in the observation group were notably higher versus the control group (P< 0.05). Moreover, the gastrointestinal function of the patients in the observation group exhibited a more favourable condition after treatment (P< 0.05). Conclusions: TCM-characteristic rehabilitation management can effectively ameliorate inflammatory responses and stress injury in patients undergoing postoperative chemotherapy for LC and enhance their immune and gastrointestinal functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.